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ABBREVIATIONS
Aβ  amyloid β-peptide
AFM atomic force microscopy
CD circular dichroism
cyt c cytochrome c
FTIR  Fourier-transform infrared
HF hydrogen fluoride
Nle91 chemically modified cytochrome c bearing a norleucine residue at position 91 
RFI relative fluorescence intensity
wt wild type, the naturally occurring form of a protein
[Zn2+-heme] cyt c cytochrome c with Zn2+-substituted porphyrin
XPOPG mole fraction of a phospholipid species in a liposome of mixed composition
 In the text, each phospholipid molecule is given a four letter abbreviation, with the two first let-
ters corresponding to the sn-1 and sn-2 side chain fatty acids, respectively, and the next two letters 
corresponding to the headgroup. For example, 1-palmitoyl-2-oleyl-sn-glycero-3-phospho-rac-
glycerol is abbreviated POPG.
Phospholipid side chains are abbreviated as follows:
P palmitic acid
O oleic acid
S stearic acid
Phospholipid headgroups are abbreviated as follows: 
PC phosphatidylcholine
PG phosphatidylglycerol
PE phosphatidylethanolamine
PS phosphatidylserine
Phospholipids with mixed or unspecified side chains are abbreviated with only two letters that 
correspond to the headgroup. 
Synthetic and special phospholipids are abbreviated as follows: 
CL  cardiolipin 
PPDPG 1-palmitoyl-2-[10-(pyren-1-yl)decanoyl]-sn-glycero-3-phosphoglycerol
PPDPC 1-palmitoyl-2-[10-(pyren-1-yl)decanoyl]-sn-glycero-3-phosphocholine
NBD-PG 1-palmitoyl-2-(N-4-nitrobenz-2-oxa-1,3-diazol)aminocaproyl-sn-glycero- 
3-phosphoglycerol
P(Br2)SPG 1-palmitoyl-2-(9,10)-dibromo-sn-glycero-3-phospho-rac-glycerol
brain-PS phosphatidyl serine purified from bovine brain
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ABSTRACT
The ability of the peripherally associated membrane protein cytochrome c (cyt c) to bind 
phospholipids in vitro was studied using fluorescence spectroscopy and large unilamellar 
liposomes.
Previous work has shown that cyt c can bind phospholipids using two distinct mecha-
nisms and sites, the A-site and the C-site. This binding is mediated by electrostatic or 
hydrophobic interactions, respectively. Here, we focus on the mechanism underlying 
these interactions.
A chemically modified cyt c mutant Nle91 was used to study the ATP-binding site, 
which is located near the evolutionarily invariant Arg 91 on the protein surface. This site 
was also demonstrated to mediate phospholipid binding, possibly by functioning as a 
phospholipid binding site.
Circular dichroism spectroscopy, time resolved fluorescence spectroscopy of zinc-
porphyrin–modified [Zn2+-heme] cyt c and liposome binding studies of the Nle91 mutant 
were used to demonstrate that ATP induces a conformational change in membrane-
bound cyt c. The ATP-induced conformational changes were mediated by Arg 91 and 
were most pronounced in cyt c bound to phospholipids via the C-site.
It has been previously reported that the hydrophobic interaction between phospho-
lipids and cyt c (C-site) includes the binding of a phospholipid acyl chain inside the 
protein. In this mechanism, which is known as “extended phospholipid anchorage,” the 
sn-2 acyl chain of a membrane phospholipid protrudes out of the membrane surface and 
is able to bind in a hydrophobic cavity in cyt c.  Direct evidence for this type of bind-
ing mechanism was obtained by studying cyt c/lipid interaction using fluorescent [Zn2+-
heme] cyt c and fluorescence quenching of brominated fatty acids and phospholipids.
Under certain conditions, cyt c can form fibrillar protein-lipid aggregates with neg-
atively charged phospholipids. These aggregates resemble amyloid fibrils, which are 
involved in the pathogenesis of many diseases. Congo red staining of these fibers con-
firmed the presence of amyloid structures. A set of phospholipid-binding proteins was 
also found to form similar aggregates, suggesting that phospholipid-induced amyloid 
formation could be a general mechanism of amyloidogenesis.
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Structure of cytochrome c
Cytochrome c (cyt c) is a globular 13-kDa protein. It is water soluble and basic, with a net 
positive charge of +8 at neutral pH and an isoelectric point of almost 10. The native con-
formation of cyt c consists of a predominantly α-helical structure folded around a cova-
lently bound heme group (Bushnell et al, 1990). In eukaryotes cyt c is encoded by a nuclear 
gene that is translated by cytosolic ribosomes into a precursor form known as apocyto-
chrome c (Moore & Pettigrew, 1990). Apocytochrome c is transported into the mitochondria, 
where it is converted to cytochrome c by the enzyme cytochrome c heme lyase, which 
covalently adds the heme group. The covalent addition of the heme group induces the 
spontaneous folding of cyt c into its native conformation from the random coil confor-
mation of apocytochrome c without the aid of chaperones (Stuart & Neupert, 1990). In mul-
ticellular organisms, cyt c is an electron transfer protein and an initiator of apoptosis. In 
mitochondria, it peripherally binds to the inner mitochondrial membrane and shuttles 
electrons from cytochrome c reductase (complex III) to cytochrome c oxidase (complex 
IV) (Moore & Pettigrew, 1990). During programmed cell death, cyt c is released from the 
mitochondria into the cytoplasm, resulting in the induction of apoptosis (Ow et al, 2008). 
Mammalian cyt c is 104 amino acids long, and 27 of these residues are invariably 
conserved across eukaryotes. Furthermore, only conservative substitutions are present in 
many other residues. The conservation of these amino acids indicates that these locations 
are likely to be critical to the structure and function of this protein. Clearly, most of these 
locations have a role in maintaining the secondary and tertiary structure of the protein 
or are responsible for interactions between cyt c and its redox partners in the respiratory 
chain. While specific amino acids in natively folded cyt c are known to mediate the apop-
totic function of cyt c (Hao et al, 2005), other conserved amino acids, including the highly 
invariant Arginine 91, do not seem to be involved in any of the known functions of cyt c, 
and the reason for their evolutionary conservation remains unclear.
The prosthetic heme group is covalently linked to the peptide chain at Cys 14 and Cys 
17. Under physiologic conditions, the heme iron is additionally bound by two coordi-
nate axial ligands, His 18 and Met 80 (Figure 1) (Bushnell et al, 1990). Met 80 is particularly 
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important, as changes in its coordination give rise to specific changes in the absorption 
and CD spectra, reflecting conformational changes during lipid binding (II, III) (Santucci 
& Ascoli, 1997; Zucchi et al, 2003).
Phospholipid binding by cyt c
Cyt c has been the paradigm for peripherally associated membrane proteins for more 
than three decades (Nicholls, 1974). It is of central biological importance and is readily avail-
able as a reagent; therefore, it has become the most commonly used model for protein-
membrane interactions and phospholipid binding. A considerable body of literature 
focusing on cyt c–lipid interactions has accumulated (Kalanxhi & Wallace, 2007).
Cyt c binds to acidic phospholipid–containing membranes at low and moderate ionic 
strengths. A critical surface charge density and an overall negative charge on the mem-
brane are required for binding (Mustonen et al, 1987): uncharged and zwitterionic phospho-
lipid membranes are not readily bound by cyt c. After electrostatic connections to the 
phospholipid are made, hydrophobic interactions also develop, as demonstrated by the 
inability to dissociate cyt c from the membranes with ATP or by increasing the ionic 
strength (Rytömaa & Kinnunen, 1994; Rytömaa & Kinnunen, 1995; Rytömaa et al, 1992). The hydropho-
bic interactions are also evident in isolated mitochondrial membranes, as a portion of 
cyt c remains attached to the membrane even following exposure to high ionic strength 
solutions (Cortese et al, 1998). Acidic phospholipid binding has been demonstrated using 
numerous methods, including resonance energy transfer, ultracentrifugation, trypto-
phan fluorescence, circular dichroism, NMR, differential scanning calorimetry, reso-
nance Raman spectroscopy and surface plasmon resonance (de Jongh et al, 1992; Heimburg 
et al, 1991; Muga et al, 1991b; Mustonen et al, 1987; Pinheiro et al, 1997; Salamon & Tollin, 1996a; Salamon & 
Tollin, 1996b).
Phospholipid binding by cyt c is mediated by two different types of interactions 
that occur on different regions on the surface of the protein. At a neutral pH and with 
membranes containing a low mole fraction of acidic phospholipids, the dominant inter-
action is electrostatic. This mode has been termed “A-site” binding. At a low pH and 
with membranes containing higher levels of acidic phospholipids, increasing amounts 
of hydrogen bonding and hydrophobic interactions are seen. This mode of interaction 
which involves hydrophobic interactions has been termed “C-site” binding (Rytömaa & 
Kinnunen, 1994). Hydrophobic binding to membranes is thought to arise as a consequence 
of extended lipid anchorage, in which one of the fatty acid chains of a membrane phos-
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Figure 1
A 3-D model of cyt c.  The backbone structure is shown in green cartoon graphics.  The heme 
porphyrin (red), the iron atom (orange), the coordinate axial ligands His 18 (light blue) and Met 
80 (yellow) and the proposed lipid binding amino acids Arg 91 (blue) and Asn 52 (cyan) are rep-
resented as ball and stick models. The image was created in PyMOL software from the crystal 
structure datafile 1hrc.pdb (Bushnell et al, 1990).
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pholipid protrudes out of the membrane and incorporates into a hydrophobic channel in 
cyt c, while the other chain remains in the lipid bilayer (Kinnunen et al, 1994; Kinnunen, 1996; 
Rytömaa & Kinnunen, 1994). This type of phospholipid conformation, which promotes hydro-
phobic interactions on membrane surfaces has also been described during membrane 
fusion (Holopainen et al, 1999). The presented model has now gained general acceptance as 
a mechanism underlying the interactions with also other peripheral membrane proteins 
(Greenberg et al, 2008; Hagan et al, 2008).
Several studies have reported changes in the tertiary structure of cyt c upon lipid 
binding, including the unfolding of the protein, a reduction in the α-helical content (Muga 
et al, 1991b; Pinheiro et al, 1997; Spooner & Watts, 1991), changes in the heme iron coordination 
state (Zucchi et al, 2003) and both increases and decreases in the redox potential (Huang & 
Kimura, 1984; Salamon & Tollin, 1997). Some have also suggested that cyt c partially or com-
pletely incorporates into the phospholipid membrane (Heimburg & Marsh, 1995; Salamon & 
Tollin, 1996a). The conformational changes induced by membrane binding depend on the 
acyl chain length and the degree of saturation of the membrane phospholipid acyl chains, 
indicating that the protein interacts with the hydrophobic acyl chains in the lipid bilayer 
(Nantes et al, 2001; Stewart et al, 2000; Zucchi et al, 2003).
While there are conflicting data in the literature, it can be concluded that the binding 
of cyt c to acidic phospholipids induces a conformational change in the protein that results 
in a structure with decreased organization and reduced thermal stability that retains a 
native-like secondary structure (Muga et al, 1991a). Overall, this conformation resembles a 
molten-globule state (Pinheiro et al, 1997). In some systems, the Met 80–heme coordination 
bond is disrupted as a result of this conformational change (Oellerich et al, 2004; Stewart et al, 
2000). The degree of conformational change depends on the surface charge density of the 
membrane, in keeping with the requirements for the two different types binding (A- and 
C-sites) (Muga et al, 1991b).
In phospholipid monolayer experiments, cyt c displays two different types of inter-
actions with phosphatidylethanolamine. At low surface pressures, cyt c penetrates the 
monolayer, whereas at higher pressures cyt c is not able to penetrate the monolayer. A 
considerable amount of cyt c is bound to the monolayer surface at higher pressure, how-
ever, and this binding is sensitive to increasing salt concentrations or perfusion of the 
subphase with fresh buffer. With monolayers of cardiolipin (instead of phosphatidyl-
ethanolamine), this high surface pressure adsorption cannot be abolished with salt. The 
authors of this study concluded that the cyt c–cardiolipin complex undergoes a time-
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Figure 3
A model of cyt c binding to CL according to Sinibaldi et al., 2010 displaying the proposed acyl 
chain binding sites for two acyl chains in extended conformation. Image was kindly provided by 
Dr. Fabio Polticelli.
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2007; Sinibaldi et al, 2010). The lipid-binding sites on cyt c have been identified using mutant 
proteins prepared by bacterial co-expression of cyt c and cytochrome c heme lyase 
(Kalanxhi & Wallace, 2007; Sinibaldi et al, 2010). A hydrophobic channel exists inside cyt c that 
can accommodate an extended phospholipid acyl chain. One end of this hydrophobic 
channel opens to the surface near the invariant Asn 52 (Figure 3). Mutation of this resi-
due to isoleucine, which drastically distorts the hydrophobicity of the channel, reduces 
the CL-induced effects on the conformation of cyt c (Sinibaldi et al, 2010). The location of the 
other lipid-binding site is less clear. The area around Arg 91 constitutes an ATP-binding 
site (II) and mediates an interaction with the membrane (I). In the 3D structure, another 
hydrophobic crevice is apparent in the vicinity of Arg 91; this site has been proposed to 
be the binding site for free fatty acids (Kalanxhi & Wallace, 2007; Stewart et al, 2000). In conclu-
sion, there is now considerable evidence to support the idea that there are two distinct 
phospholipid-binding sites on the surface of cyt c located in the proximity of Arg 91 and 
Asn 52.
Cyt c in apoptosis
The canonical function of cyt c is the transfer of electrons in the mitochondrial electron 
transport chain. It is now recognized that cyt c has a second crucial activity that is funda-
mentally important for the development of multicellular organisms. During programmed 
cell death (apoptosis), cyt c is released from the mitochondria into the cytoplasm (Kluck 
et al, 1997; Liu et al, 1996). After its release, cyt c binds to proteins Apaf-1 and procaspase-9 to 
form a multimeric complex known as the apoptosome (Ow et al, 2008). Apoptosome forma-
tion requires the binding and hydrolysis of ATP or dATP. Even though dATP is a more 
effective activator of the apoptosome, ATP is more likely to be the physiologic ligand as 
it is more readily available in the cytoplasm (Kim et al, 2005; Li et al, 1997b). The formation of 
the multimeric apoptosome activates caspase-9, a proapoptotic protease that initiates the 
activation of downstream executioner caspases, such as caspase-3 and caspase-7. This 
apoptotic pathway is generally known as the intrinsic or mitochondrial pathway, and the 
release of cyt c into the cytoplasm is the rate-limiting step. Indeed, it has been demon-
strated that microinjection of exogenous cyt c into the cytoplasm is sufficient to initiate 
programmed cell death (Li et al, 1997a; Zhivotovsky et al, 1998). Therefore, simply the presence 
of cyt c in the cytoplasm is sufficient to induce apoptosis, emphasizing the importance of 
the release of cyt c from the mitochondria for regulating cell death. Proper cyt c function 
in the apoptosome requires both the entire polypeptide sequence in its natively folded 
18 · esa k. j. tuominen: phospholipid–cytochrome c interactions
conformation and the heme group. However, while the presence of the heme group is 
required, its electron transfer activity is not, as [Zn2+-heme] cyt c is functional in the 
apoptosome (Liu et al, 1996). Experiments using apoptosomes reconstituted from highly 
purified recombinant components have demonstrated that binding of cyt c to Apaf-1 
induces ATP hydrolysis by Apaf-1, however, the cyt c–binding site on Apaf-1 is distinct 
from the ATP hydrolysis site. (Kim et al, 2005). The modification of Lys 72 on the surface of 
cyt c decreases its proapoptotic potential but does not significantly affect its function in 
the electron transfer chain (Hao et al, 2005). The same region of the cyt c surface is thought 
to be involved in lipid binding (Kalanxhi & Wallace, 2007; Rytömaa & Kinnunen, 1995; Sinibaldi et 
al, 2010). To date, however, there is no direct evidence suggesting that interactions with 
phospholipids are involved in apoptosome formation after the release of cyt c from the 
mitochondria. 
Many factors regulate cyt c release and the initiation of the mitochondrial apoptosis 
pathway. The activation of proapoptotic signaling molecules, including BID, BAX and 
BAK, promotes cyt c release, while antiapoptotic molecules, such as BCL-2 and BCL-xL, 
inhibit release (Basanez et al, 2002; Kagan et al, 2005; Li et al, 1997a; Yang et al, 1997). Importantly, none 
of the regulatory proteins that control the release of cyt c from the mitochondria have 
been shown to interact with cyt c itself. Rather, these proteins predominantly contrib-
ute to the permeability of the outer mitochondrial membrane and the structure of the 
cristae formed by the inner mitochondrial membrane during apoptosis (Kagan et al, 2009). 
What seems most important for cyt c release is the attachment of cyt c to the inner mito-
chondrial membrane. Translocation through the outer mitochondrial membrane after 
detachment seems to be a secondary event and is not specific to cyt c, as many proteins of 
similar size are also released after the initiation of the mitochondrial apoptosis pathway 
(Kagan et al, 2009; Ow et al, 2008).
The physiological binding site of cyt c in the mitochondrial membrane is CL (Speck 
et al, 1983; Vik et al, 1981). This interaction is important both for the function of cyt c in the 
electron transfer chain and for preventing the release of cyt c from the mitochondrial 
intermembrane space. Recently, it has been demonstrated that mitochondrial cyt c binds 
to CL using the extended lipid anchorage (Sinibaldi et al, 2010). This mode of membrane 
binding has been proposed to induce a conformational change in cyt c and promote the 
emergence of lipid peroxidase activity in cyt c (Kagan et al, 2009; Kagan et al, 2005; Kagan et al, 
2004). Based on this model, yet unknown factors would trigger the peroxidase activity of 
membrane-bound cyt c in the mitochondria. The subsequent peroxidation of mitochon-
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drial CL would simultaneously lead to decreased membrane integrity and the detach-
ment of cyt c from CL due to its reduced affinity for peroxidated CL side chains (Belikova 
et al, 2006; Mattila et al, 2008). This model suggests that a phospholipid-mediated mechanism 
could control apoptosis and further highlights the importance of understanding the 
interactions between cyt c and phospholipids. The peroxidase activity also potentially 
explains the rationale for having heme-containing cyt c also function as an apoptotic 
protein. Altogether, the discovery of the dual functions of cyt c has challenged the old 
biological dogma of one gene producing one protein with only one unique function.
ATP binding
In vitro, cyt c binds ATP with a low millimolar affinity (Craig & Wallace, 1991a). A similar 
concentration of ATP is present in the mitochondrial intermembrane space and cytosol 
(Bjursell & Skoog, 1980). The binding of ATP to cyt c is mediated through a site that contains 
the invariant Arg 91 and nearby amino acids. ATP binding at this site can be abrogated 
by photoaffinity labeling or amino acid substitutions (McIntosh et al, 1996). Photoaffinity-
modified 8-azido-ATP cyt c also has reduced activity in the electron transfer chain (Craig 
& Wallace, 1995; Lin et al, 1995). Therefore, it has been suggested that the modulation of the 
reactivity of cyt c via ATP binding may comprise a feedback mechanism that regulates 
the electron transfer chain.
Physiological concentrations of ATP inhibit the conformational changes in cyt c that 
are induced by oleic acid. As a result, lipid binding–induced peroxidase activity is also 
reduced (Sinibaldi et al, 2005). Therefore, ATP binding influences both protein conforma-
tion and reactivity, thereby functioning as a regulatory mechanism for respiration and 
apoptosis.
Zinc-heme cyt c
Synthetic cyt c species have been created by replacing the heme iron in the heme group 
with other metal ions. The Fe2+/3+ ion in the heme group can be removed with hydrogen 
fluoride to generate an iron-free porphyrin cyt c. Porphyrin cyt c readily binds soluble 
metal ions to create metalloporphyrin cyt c species. The most widely studied of these 
species is a cyt c protein bearing a Zn2+ ion ([Zn2+-heme] cyt c) in place of the iron mol-
ecule. [Zn2+-heme] cyt c lacks the redox capabilities of wt cyt c but retains a very similar 
3D structure (Anni et al, 1995; Vanderkooi et al, 1976; Vanderkooi & Erecinska, 1975). Also, both of the 
coordinating bonds between the Zn2+ ion and His 18 and Met 80 and are present, indi-
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cating that this protein is likely to retain wt properties (Qian et al, 2003). The [Zn2+-heme] 
is intrinsically fluorescent and can be used for fluorescence spectroscopy without the 
addition of other chemical moieties (Anni et al, 1995). Wt cyt c is not fluorescent in its folded 
conformation because the heme group effectively quenches the fluorescence of the tryp-
tophan residues in cyt c. For the same reason, even wt cyt c species that are labeled with 
conventional fluorescent moieties are not useful for fluorescence studies. The fluorescent 
[Zn2+-heme] can be used alone or as a resonance energy transfer pair with tryptophans 
to monitor changes in cyt c structure (II)(Ensign et al, 2008).
 [Zn2+-heme] cyt c supports active apoptosome formation in cell-free apoptosis 
models. Therefore, the redox activity of cyt c is not required for the induction of apop-
tosis after its release from the mitochondria (Liu et al, 1996), further indicating that [Zn2+-
heme] cyt c behaves similarly to the wt protein.
Amyloid fibers
Some proteins or peptides can convert from their native soluble conformations into 
ordered fibrillar aggregates. The accumulation of these fibrous aggregates in tissues 
occurs during many diseases, including neurodegenerative Alzheimer’s disease, prion 
diseases and systemic amyloidosis. These highly organized fibrillar aggregates are called 
amyloid deposits because the pathologist who discovered them first believed they were 
composed of carbohydrates (Virchow, 1854). The deposits found in diseased individuals 
actually consist predominantly of polymerized polypeptides in a repeating β-sheet con-
formation (Aguzzi & O’Connor, 2010; Chiti & Dobson, 2006). Electron microscopy and AFM have 
shown that these aggregates are organized as protofilaments that are twisted together to 
form rope-like ribbons. Each protofilament is approximately 2–5 nm in diameter, and 
bundles of protofilaments form up to 30 nm wide ribbons. These elongated structures 
are termed fibrils, and they can be macroscopic in scale (Saiki et al, 2005; Serpell et al, 2000). 
Because they are not crystalline enough to be studied using diffraction methods and 
are too heterogeneous for NMR spectroscopy, it has been a challenge to acquire any 
detailed structural information regarding these aggregates. Recent advances in spectro-
scopic methods, however, have revealed more about the molecular structure of these 
aggregates. While the amyloid structures are basically polymers that are rich in pleated 
β-sheets, there is now also evidence for structural heterogeneity. Indeed, several different 
structural forms of the same amyloidogenic polypeptide have been found in individual 
fibers (Chiti & Dobson, 2006; Chiti & Dobson, 2009; Luhrs et al, 2005; Sawaya et al, 2007).
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Overall, more than 40 diseases with fibrous protein aggregate deposits have been 
described. Each of these diseases has a distinct clinical profile and is associated with 
the aggregation of a single dominant protein or peptide. Some of these conditions are 
hereditary, caused by mutations in the dominant polypeptide, but most are considered 
sporadic, in which the deposited protein or peptide has a wt sequence. In addition, there 
are transmissible forms of amyloid diseases, such as transmissible spongiform encepha-
lopathy. In these diseases, the transmission of a small amount of the fibrous deposits to a 
healthy individual triggers amyloid deposition in the recipient. No abnormal or foreign 
genetic material, such as bacterial or viral DNA or RNA, is needed to transfer these 
diseases. Therefore, it seems that the abnormal folding of an otherwise normal protein is 
the underlying mechanism of these diseases. Interestingly, the proteins or peptides that 
cause these diseases do not seem to share any structural or conformational homology 
until they are in the aggregated state. They range in size from 23 to over 1000 amino acids. 
In their native forms, all types of secondary and tertiary structure are represented. Many 
of these proteins are water-soluble, globular proteins with no propensity to polymerize. 
In fact, the factors that contribute to the amyloidogenicity of a protein remain largely 
unknown (Aguzzi & O’Connor, 2010; Chiti & Dobson, 2006).
The detection and characterization of amyloid protein aggregates in histological 
samples and in vitro relies on specific dyes that intercalate into the pleated-β sheet struc-
ture of the amyloid fibers. The most commonly used compound is the azo-dye Congo 
Red, although other dyes, such as Thioflavins, can also be used. Amyloid-bound Congo 
Red molecules that are intercalated into the pleated-β sheet are oriented such that they 
emit an apple-green birefringence upon exposure to polarized light (Nilsson, 2004). The 
detection of this birefringence has remained a standard technique for amyloid detection 
(Alakoskela et al, 2006; Heikenwalder et al, 2007). The specificity of Congo Red staining has been 
questioned as Congo Red has also been shown to stain smaller protein aggregates that 
do not strictly fit the classic definition of amyloid deposits in tissue (Khurana et al, 2001). 
However, these aggregates may still be significant disease-related protein deposits (Aguzzi 
& O’Connor, 2010).
Amyloid formation initiates with proteins that are in their native functional conforma-
tion and the physicochemical steps leading to the formation of the amyloid structure 
and the subsequent polymerization into fibrils remain unclear. Proteins associated with 
pathogenic amyloid deposits, as well as many non-disease associated proteins, form 
amyloid fibrils in vitro (Rochet & Lansbury, 2000). Usually, the native form of the amyloido-
22 · esa k. j. tuominen: phospholipid–cytochrome c interactions
genic protein is fully folded, nontoxic and soluble. In vitro, amyloid formation is pro-
moted by denaturing conditions, such as low pH, high temperature, high pressure or the 
presence of non-aqueous solvents (Schmittschmitt & Scholtz, 2003). A reduction in the overall 
net charge and a low dielectric environment also enhance rapid fiber formation (Rochet 
& Lansbury, 2000). These data support a model in which a conformational change, possibly 
the partial unfolding of the protein, is required to initiate the aggregation and subsequent 
folding into the amyloid-type conformation. Once aggregation has started, the aggregate 
may serve as a template for additional protein molecules, leading to rapid aggregation. 
Most of the known mutations that are associated with the hereditary forms of amyloid 
deposition diseases have been shown to decrease the conformational stability of the 
native fold (Sekijima et al, 2005). Accordingly, any condition that promotes changes in the 
conformation of the protein may also promote amyloid formation by making alternative 
folding pathways thermodynamically more accessible. The conditions used to induce 
amyloid formation in vitro are rather harsh and probably not physiologically relevant. 
Instead, it may be feasible that binding to acidic phospholipids would induce the confor-
mational changes that initiate amyloid formation under physiological conditions.
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AIMS OF THE STUDY
This dissertation focuses on the interaction between phospholipids and the peripheral 
membrane protein cytochrome c. Cytochrome c is an important biological molecule and 
a model of peripherally associated membrane proteins.
These aims provided the basis for the studies:
1) To investigate the molecular mechanism underlying the interaction between cyto-
chrome c and phospholipids. I–IV
2) To demonstrate that extended phospholipid anchorage is an effective mechanism for 
peripheral protein–membrane interactions. III
3) To characterize amyloid-containing protein fibers formed by peripheral membrane 
proteins following interaction with acidic phospholipids. IV
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MATERIALS AND METHODS
Reagents
Pyrene-labeled phospholipid derivatives (PPDPC, PPDPG) were obtained from K&V 
Bioware (Espoo, Finland). Other phospholipids and NBD-PG were obtained from Sigma 
or Avanti Polar Lipids (Alabaster, AL). The modified cyt c species were obtained from 
our collaborators in the group of Dr. Carmichael Wallace. ATP was purchased from 
Roche Molecular Biochemicals. The phospholipid purity was routinely assayed using 
thin layer chromatography on silicic acid using chloroform:methanol:water:ammonia 
(65:20:2:2, v/v) as a solvent system; plates were examined for fluorescence or following 
iodine staining. All other reagents were obtained from typical commercial suppliers. 
Cyt c solutions
We used oxidized, horse heart–derived, wild type cyt c from Sigma unless otherwise spec-
ified. To prepare the stock and working solutions, dry, lyophilized protein was weighed 
and dissolved either in H2O or buffer, usually 20 mM HEPES/0.1 mM EDTA, pH 7.0. 
The redox state and concentrations were determined by spectrophotometry (Margoliash & 
Frohwirt, 1959). The redox state of the dissolved protein from the commercial source was 
consistently at least 98% oxidized and was used as such in experiments with oxidized 
cyt c. To obtain the reduced form of cyt c, solid sodium dithionite was added to a con-
centrated cyt c solution until no further change in solution color could be seen. After 
reduction, the solution was eluted from a disposable gel column in the desired buffer 
(Sephadex PD-10, Amersham Biosciences, Uppsala, Sweden) to remove the inorganic 
reaction products and excess reducing agent. The fractions containing cyt c were pooled 
and used as a stock solution for experiments after determining the concentration. Cyt c 
solutions were stored at -20°C and kept on ice after thawing. 
The cyt c derivative in which Arg 91 was replaced with norleucine (Nle91) was pre-
pared by Dr. Wallace and his group using the advanced protein chemistry methods 
described in the Methods section of paper II and the references therein.
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Preparation of the [Zn2+-heme] cyt c 
The substitution of Zn2+ for Fe2+ in the porphyrin of cyt c yields an intensely fluorescent 
derivative (Vanderkooi et al, 1976). This analog has been characterized in considerable detail 
and has been shown to closely resemble the parent protein in most qualities. Therefore, it 
is a good model for studying the conformation of cyt c (Anni et al, 1995). The [Zn2+-heme] 
cyt c derivative was prepared from horse cyt c as described by Vanderkooi and Erecinska 
(Vanderkooi & Erecinska, 1975). To obtain iron-free cyt c, HF was first added to generate por-
phyrin cyt c. The porphyrin cyt c was then treated with ZnCl2 in an aqueous solution 
to generate [Zn2+-heme] cyt c (Vanderkooi et al, 1976). The final product was purified using 
ion-exchange chromatography and then transferred into the desired buffer using a dis-
posable gel filtration column, as described for wt cyt c. In the experiments, [Zn2+-heme] 
cyt c was handled similarly to wt cyt c.
Fluorescence spectroscopy
Lipid binding to cyt c was monitored by measuring the resonance energy transfer 
between pyrene-labeled lipid PPDPG and the heme group of cyt c, as described previ-
ously. When the absorbing heme group is in close proximity to the fluorescent pyrene 
group in the liposomal membrane, Förster resonance energy transfer quenches the fluo-
rescence. This effect is used to measure the association of heme-carrying cyt c molecules 
with liposomes (Förster, 1948; Rytömaa & Kinnunen, 1995; Stryer, 1978). The measurements were 
conducted using a Perkin-Elmer LS50B spectrofluorometer with bandpass filters of 2.5 
nm to 5.0 nm for excitation and emission, as required by the signal intensity. Liposome 
solutions with phospholipids at final concentration of 25 μM were added to a magneti-
cally stirred 4-window quartz cuvette. The cuvette holder was equilibrated at 25°C. Cyt c 
was titrated in aliquots of 5–10 μl. The indicated amount of ATP was added either to the 
buffer before preparing the liposomes or after cyt c binding. When ATP was added after 
cyt c binding, it was titrated in 5 µl aliquots of a 200 mM stock solution until the desired 
final concentration was reached. The pH of the ATP stock solution was adjusted to pH 
7.0 with NaOH. For steady state measurements, the change in fluorescence was allowed 
to stabilize for 40 s before the signal was recorded. Because of the low concentrations of 
both cyt c and lipids that were used, only minimal interference from the inner filter was 
expected. 
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90-degree light scattering
The 90-degree angle scattering of 500 nm light was used to assay cyt c binding to large 
unilamellar vesicles (LUVs), as described by Nelsestuen and Lim (Nelsestuen & Lim, 1977). 
The intensity of light scattering at 90-degrees was measured using a spectrofluorometer 
with bandwidths set to a minimum at a 500 nm wavelength. The signal was recorded 
continuously to produce an uninterrupted signal/time graph. Otherwise, the conditions 
used were the same as those described in the Fluorescence Spectroscopy section. The 
scattering from buffer or unbound cyt c in the absence of liposomes was negligible. 
Preparation of liposomes
The small-pore extrusion method was used to prepare large unilamellar phospholipid 
vesicles in an aqueous solution (MacDonald et al, 1991). Phospholipids were mixed from stock 
solutions in CHCl3 or 9:1 CHCl3:MeOH to yield the desired lipid compositions. The 
organic solvent was removed by evaporation under a gentle stream of nitrogen, and the 
tube was kept under reduced pressure for at least 2 h to remove the remaining trace 
amounts of solvent. The dried lipids were hydrated in buffer at room temperature with 
vigorous vortexing to yield concentrations of 1–3 mM. The hydrated lipid dispersions 
were extruded 15–19 times through double 100 nm polycarbonate membranes using a 
LiposoFast pneumatic small-volume homogenizer (Avestin, Ottawa, Canada). According 
to published data, this method produces a uniform population of unilamellar vesicles with 
an average diameter between 111 and 117 nm (Berger et al, 2001; MacDonald et al, 1991; Wiedmer et 
al, 2001). The extruded liposome solutions were then divided into aliquots and diluted with 
buffer to the desired concentrations. Liposomes were stored at +4°C for a maximum of 2 
days prior to use.
After publication of the experiments described in this dissertation, the vesicle size was 
measured directly using a dynamic light scattering instrument (Malvern Instruments, 
Worcestershire, United Kingdom). After preparing the liposomes in 20 mM HEPES/0.1 
mM EDTA, pH 7.0, using this method, the average size was 111.1 ± 14.35 nm and 100.3 
± 17.5 nm for the XPG=0.2/XPG=0.8 and XPG=1.0 liposomes, respectively.
Circular dichroism spectroscopy
Circular dichroism (CD) spectra were collected using an Olis RSF 1000F CD spectro-
photometer (On-line Instrument Systems, Bogart, GA, USA). This instrument is a dual 
beam setup with two photomultiplier tubes used for gathering circular dichroism data. 
MATERIALS AND METHODS · 27
The light source was a water-cooled 150 W Xenon lamp. The CD spectra were collected 
in cylindrical CD cells with quartz windows. The measurement cell was thermally con-
trolled with a circulating water bath; a temperature of 25°C was used for all experiments.
The Soret region CD spectra of cyt c in the 380–460 nm range were recorded in 10 
mm path-length cells. The final spectra, representing the average of at least three tracings, 
were background-corrected. The cyt c CD data are expressed as the difference between 
the extinction coefficients for left- and right-circularly polarized light calculated per 
heme.
Brominated lipids
The brominated lipid derivates 9,10-dibromostearic acid and 1-palmitoyl-2-(9,10)-
dibromo-sn-glycero-3-phospho-rac-glycerol used in the study were produced from oleic 
acid and POPG, respectively. Br2 reacts with the double bond of the oleic acid moiety by 
addition (Figure 5). 
Lipids (approximately 1 µmole) were dissolved in 1 ml of octane, and a solution of 5% 
Br2 (w/v) in octane was added in 2 µl aliquots until the mixture became the color of molec-
ular bromine. The solutions were immediately stored at –20°C for at least 24 h. Unreacted 
bromine was removed by evaporation under reduced pressure and by chromatography 
on a silicic acid column eluted with CHCl3:MeOH (7:3, v/v). The purity of the prod-
ucts was verified by thin layer chromatography in chloroform:methanol:water:am monia 
(65:20:2:2, v/v); a single band was evident following iodine staining (Dawidowicz & Rothman, 
1976). 
Fiber formation and imaging of the fibers
To form the protein-lipid fibers that were studied in paper IV, protein was slowly added 
to a magnetically stirred liposome solution (25 µM lipid concentration), and the solution 
was incubated overnight with continuous stirring. The fibers were collected by pipette, 
transferred onto glass slides and observed using bright field, phase contrast or fluores-
cence microscopy with an Olympus IX 70 inverted microscope (Olympus Optical, Tokyo, 
Japan). Where indicated, the fibers were incubated with 10 µM Congo red, and the result-
ing birefringence was observed using crossed polarizers in the excitation and emission 
paths. Images of NBD-PG-labeled fibers were taken with a confocal fluorescence micro-
scope equipped with a spinning disk confocal scanner (Yokogawa, Tokyo, Japan) and a 
488 nm krypton ion laser light source (Melles Griot, Carlsbad, CA). A long pass filter 
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dependent conformational change that is triggered by an interaction with the phospho-
lipid acyl chains (Quinn & Dawson, 1969a; Quinn & Dawson, 1969b).
Usually, extended lipid anchorage is not considered a possible mechanism for pro-
tein-phospholipid binding in the studies mentioned above. The ability of a peripheral 
membrane protein to interact with membrane fatty acids without inserting into the 
membrane could readily explain many of these observations (Gennis, 1989; Hagan et al, 2008; 
Jensen & Mouritsen, 2004; Kinnunen, 1996; Kinnunen, 1999; Mouritsen, 2005).
The adoption of an extended phospholipid conformation would only require the 
rotation of the C2-C3 carbon bond of the glycerol backbone. This rotation will lead to 
the protrusion of the sn-2 acyl chain out of the lipid bilayer, allowing it to interact with 
peripheral membrane proteins (Hauser et al, 1980; Hauser et al, 1988). In natural phospholipids, 
the presence of a saturated side chain in sn-1 and an unsaturated side chain in sn-2 is 
conspicuous (Gennis, 1989). The greater structural diversity of sn-2 side chains suggests 
that they are indeed more likely than sn-1 side chains to take part in biological reactions 
(Figure 2). This reactivity would be possible in an extended phospholipid conformation.
More recently, the extended lipid anchorage model has been accepted as a valid 
mechanism for the interaction between cyt c and lipids (Kagan et al, 2009; Kalanxhi & Wallace, 
Figure 2
Panel A: The chemical structure of the phospholipid POPG showing structural components of a 
phospholipid molecule.
Panel B: A CPK model of a POPG molecule in the extended conformation. The sn-2 acyl chain 
readily adopts this conformation by rotation of a single carbon bond in the glycerol backbone.
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(>510 nm) was used to filter out the excitation light when monitoring NBD-fluorescence. 
Images were acquired with a Hamamatsu monochrome camera (C4742-95-12 NRB, 
Hamamatsu Photonics K.K., Hamamatsu, Japan) operated with AquaCosmos software 
from the manufacturer. Color bright field, phase contrast and fluorescence images were 
taken using a CMOS SLR camera (Canon EOS-10D) connected to the microscope. 
Adobe Photoshop software was used to process the microscope images into a suitable 
format for publication. The image manipulation techniques used during processing were 
restricted to adjustments of the contrast, color balance and printing resolution.
Figure 4
A schematic representation of a large unilamellar vesicle with cyt c molecules bound onto its sur-
face.  The diameter of the vesicles used in this study was approx. 100 nm.
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RESULTS
The invariant Arg91 is required for the aggregation of liposomes 
by cyt c (I)
The Nle91 mutant cyt c was prepared to study the previously reported high affinity ATP-
binding site of cyt c (Corthesy & Wallace, 1986; Corthesy & Wallace, 1988; Craig & Wallace, 1991a; Wallace 
& Rose, 1983). The binding of this mutant to large unilamellar vesicles was measured using 
resonance energy transfer between the membrane-embedded pyrene and the heme group 
of cyt c. The resonance energy transfer assay following lipid binding revealed no differ-
ences between the mutant and the wt proteins (I, Fig. 1). At the end of the experiment, 
however, increased turbidity was observed in the wt samples, but not in the samples 
containing the Nle91 mutant. The resonance energy transfer assay strictly monitors the 
average proximity of the heme group to the donor lipid. Especially when there is nearly 
saturated binding and the majority of the fluorescence is quenched, it does not account 
for changes in the lipid bilayer structure or for aggregation of the liposomes.
To learn more about this process, we used the 90° light scattering assay described by 
Nelsestuen and Lim. For large unilamellar vesicles and peripherally bound proteins, the 
scattering intensity mostly reflects the mass of the scattering particle, i.e., the amount 
of protein bound on the liposome surface (Nelsestuen & Lim, 1977). Scattering was recorded 
continuously during the addition of wt or Nle91 cyt c to assess the kinetics of binding. For 
the wt protein, the light scattering intensity was found to drop drastically after the cyt c 
concentration exceeded 0.4 µM. The scattering intensity was actually lower than the level 
of scattering caused by liposomes alone (I, Fig. 2), probably due to the aggregation and 
subsequent rupture and fusion of the liposomes. The particle size was also dramatically 
different, and the contributors to signal intensity did not match those of the original 
experimental setup. While a detailed analysis of the kinetics of this process could not be 
achieved with our experimental setup, we did note that the addition of excess cyt c after 
the initial aggregation further accelerated the process. With the Nle91 mutant, the scat-
tering saturated at a well-defined level correlating with the amunt of membrane bound 
protein bound to the membrane and there was no indication of liposome aggregation. 
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Furthermore, the signal appeared to reach a steady state after each addition and rapid 
binding of Nle91ding to liposomes (I, Fig. 2).
The cyt c concentration required for liposome aggregation roughly corresponded to 
the concentration required to neutralize the surface charge on the liposomes. Yet, the 
modification of a single amino acid on the protein surface was found to prevent aggrega-
tion. This result suggests that lipid aggregation is mediated by a specific site-mediated 
lipid interaction rather than being nonspecific aggregation due to decreased repulsion 
between the liposomes after protein binding.
ATP binding induces a conformational change 
in C-site lipid–bound cyt c (II)
Previous work has demonstrated that while ATP can dissociate cyt c bound to phos-
pholipid liposomes through its A-site, it does not reverse the hydrophobic interactions 
mediated by the C-site (Rytömaa & Kinnunen, 1995). In publication II, the effects of ATP to 
lipid-bound cyt c in the conditions that promote C-site interactions are described. 
Experiments using fluorescence resonance energy transfer to study the binding of 
cyt c to large unilamellar liposomes containing pyrene-labeled phospholipid analog 
PPDPC demonstrated that enhanced transfer occurs in the presence of ATP (II, Fig. 1). 
This effect has also been reported elsewhere and can be explained either by increased 
membrane association of cyt c molecules or by changes in the orientation of the heme 
groups related to the fluorescently labeled membrane. The latter can occur as a result of 
conformational changes caused by binding of ATP to membrane bound cyt c (Rytömaa & 
Kinnunen, 1994). This possibility was further studied using circular dichroism spectroscopy 
(CD) of the heme group absorbance in the Soret region (380–440 nm). The underlying 
mechanisms of dichroic optical activity in the Soret region are not exactly defined, and 
therefore the peaks in the CD spectrum are not specifically assigned to any chemical 
moieties. Nevertheless, changes in the CD spectra in this region are sensitive indicators 
of the conformational environment of the heme group (Blauer et al, 1993). The trough in the 
spectrum at 420 nm has been previously assigned to the coordinating bond between the 
heme iron and the Met 80 residue of cyt c by denaturation studies (Santucci & Ascoli, 1997).
The CD spectra for cyt c in solution and for A-site lipid–bound cyt c are similar in 
shape and match previously published results (Santucci & Ascoli, 1997). ATP does not induce 
any detectable change in the CD spectrum of cyt c under these conditions (II, Fig. 2).
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The recorded CD spectrum of C-site membrane–bound cyt c (at XPOPG=1.0 in pH 7.0) 
is very different from the spectrum of soluble and A-site-bound cyt c. The peak at 410 
nm and the trough at 420 nm are reversed and a wide positive band emerges at 390 nm. 
In the presence of 3 mM ATP, the shape of the spectrum changes even more, with a new 
peak forming at 405 nm (II, Fig. 2 panel C).
The spectrum recorded for the C-site-bound cyt c suggests that lipid binding disrupts 
the Fe-Met 80 coordinating bond, indicating that the overall conformation of the protein 
is different. ATP induces additional changes in the spectrum of the C-site lipid–bound 
cyt c. Both of these spectra have distinct shapes, including sharp peaks and a rotational 
strength equal to unbound protein. Therefore, they probably represent organized confor-
mations rather than a simple molten globule or denatured random coil states.
Time-resolved fluorescence spectroscopy of [Zn2+-heme] cyt c was used to further 
investigate the lipid- and ATP-induced conformational changes. The [Zn2+-heme] group 
is intrinsically fluorescent, and changes in its emission lifetime reflect differences in 
the environment surrounding this prosthetic group. The emission lifetime data for the 
[Zn2+-heme] cyt c were consistent with the results of the CD spectroscopy. Only modest 
differences were detected in the emission lifetimes of soluble and A-site lipid–bound 
[Zn2+-heme] cyt c. For the C-site-bound [Zn2+-heme] cyt c, the presence of 1 mM ATP 
induced a dramatic increase in the average emission lifetime, indicating that a conforma-
tional change occurred (II, table I).
The high-affinity ATP-binding site of cyt c is compromised in the Nle91 analog. 
Changing the arginine side chain to a straight aliphatic chain deletes the positive charge 
that contributes to ATP binding without disturbing the overall protein conformation. 
The C-site lipid-binding properties of this modified cyt c were found to be identical to wt 
cyt c. In the presence of ATP, the enhanced quenching effects were found to be somewhat 
diminished yet noticeable (II, Fig. 4). These data were interpreted as a partial loss of the 
ATP-binding site in the Nle91 analog. Affinity column data confirm this incomplete loss 
of ATP binding in the Nle91 analog (II, table II). Together, these results suggest that this 
Arg 91-containing site is important in the ATP-induced conformational changes.
Extended lipid anchorage (III)
The interaction between reduced cyt c and oleic acid induces changes in the absorption 
spectrum that resemble those caused by the oxidation of cyt c. Previous studies have 
shown that this effect is caused by a spin state change in the heme iron after disruption 
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of the Met 80–heme coordinating bond due to a conformational change rather than the 
oxidation of the protein (Nantes et al, 2001; Stewart et al, 2000).
Consistent with previously published data, the spectrum of reduced cyt c lost its dou-
ble-peak nature, and a shift to a lower wavelength in the Soret band region was detected 
(III, Fig. 1). These effects are detectable even with concentrations of oleic acid that are 
below the critical micellar concentration, suggesting that this effect is due to an interac-
tion between the fatty acyl chain itself and cyt c, rather than being a nonspecific detergent 
effect.
We investigated whether fatty acyl chains could induce similar spectral changes when 
interacting with cyt c in phospholipid bilayers. Cyt c was incubated with LUVs contain-
ing various XPG and excess lipid concentrations. An identical change in the spectrum 
of cyt c was observed for liposomes containing XPG=1.0, suggesting that the liposomal 
phospholipid acyl chains are able to interact with membrane-bound proteins in a manner 
similar to free oleic acid in solution (III, Fig 2). These fatty acyl chain–induced changes 
did not occur with liposomes at a low XPG, but evolved rapidly when the acidic phospho-
lipid content was raised over XPG=0.6 (III, Fig. 3). The dependence of this effect on the 
phospholipid composition is identical to what has been observed for hydrophobic C-site 
binding of cyt c (Rytömaa & Kinnunen, 1994), suggesting that these two interactions share a 
common mechanism.
The fluorescence of [Zn2+-heme] cyt c depends on the immediate environment of the 
zinc-porphyrin group. We took advantage of this property to study the mechanism of 
fatty acid binding. Bromine is a well-known collision quencher that can quench the emis-
sion of fluorophores following direct contact (Bolen & Holloway, 1990). We used brominated 
fatty acids and phospholipids with brominated acyl chains to detect fatty acid binding in 
the interior of cyt c by measuring the quenching of the [Zn2+-heme] cyt c fluorescence.
We first assessed the effect of non-brominated lipid species on the fluorescence. We 
observed that the addition of non-brominated oleic acid caused a biphasic change in the 
fluorescence of [Zn2+-heme] cyt c. After an initial decrease in fluorescence intensity at 
protein:lipid ratios up to 1:20, the intensity recovered and reached saturation at approxi-
mately 90% of the initial level at approximately a 1:40 protein lipid ratio (III, Fig. 4). 
Similar, yet more pronounced behavior was detected for POPG vesicles (III, Fig. 5). The 
biphasic response suggests that the interaction could occur through a two-step binding 
process, or that there are two different binding sites on cyt c. Other authors have also pro-
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posed the existence of two separate hydrophobic binding channels in cyt c, as depicted in 
Figure 3 (Kalanxhi & Wallace, 2007; Sinibaldi et al, 2010).
Brominated oleic acid [(9,10)-dibromostearate] and the corresponding brominated 
phospholipid P(Br2)SPG were found to induce a significantly more pronounced decrease 
in fluorescence intensity than unbrominated fatty acids (III, Figs 4 and 5), presumably 
because the proximity of the bromine groups in the fatty acid chains to the [Zn2+-heme] 
group inside the protein caused quenching. This effect is even easier to appreciate when 
the relative [Zn2+-heme] fluorescence was normalized to the intensity measured for the 
identical concentration of nonbrominated fatty acids. We observed pronounced quench-
ing by (9,10)-dibromostearate and P(Br2)SPG, which saturates at 20–30 µM lipid, cor-
responding to a cyt c:lipid molar ratio of 1:30–1:40 (III, Fig. 6). The efficient quenching 
by the brominated fatty acid moiety provides direct evidence for an interaction between 
this lipid and the [Zn2+-heme] moiety in the interior of cyt c.
Figure 5
Panel A: Br2 reacts with the double bond of the oleic acid moiety by addition, yielding 9,10-dibro-
mostearic acid.
Panel B: The chemical structure of the brominated POPG, P(Br2)SPG
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Fibrous cyt c–phospholipid aggregates (IV)
During the course of the experiments described in paper I, we observed the formation 
of red fibrous aggregates of cyt c and phospholipids. During the 90-degree light scatter-
ing experiments, thin red fibers were visible in the cuvettes after titrating in cyt c. This 
particular experiment takes up to an hour to complete, as the cyt c solution is slowly 
titrated into a continuously stirred solution of liposomes. The conditions that seemed 
to support fiber formation included the presence of acidic phospholipids, an incubation 
time of 1 hour or more, continuous stirring and rather dilute lipid concentrations, i.e., 
10–100 µM lipid. 
When the fibers were viewed under a bright field microscope, several different popula-
tions of fibers could be observed, even within a single incubation sample. The fibers were 
typically between 0.2-5.0 mm long and 5-50 µm thick; no correlation between length 
and thickness was observed. The fibers appeared to have relatively straight, ribbon-like 
segments that were occasionally twisted into helical structures. Some fibers or parts of 
fibers appeared frayed or had smaller fibers sticking out of the surface of the main core 
fiber. The fiber structure was composed of smaller thin fibrils; the size of these fibrils was 
smaller than what could be readily observed using optical microscopy. The helicity also 
suggested that the fiber was a periodic superstructure composed of repeating structural 
motifs (IV, Fig. 1).
A spectrum of colors could be seen in the fibers. Some of the fibers were predomi-
nantly red, as can be expected from the absorption spectrum of cyt c, but nearly colorless 
fibers could also be observed. A small fraction of fibers actually had a blue or magenta 
tint. Furthermore, a single fiber could exhibit structural transitions along its length. For 
example, a single fiber could have both blue and red segments, segments with visibly 
separated ribbons or segments that transition between a rippled and smooth surface. The 
thickness of a fiber was fairly constant, even with the heterogeneity in the superstructure. 
This heterogeneity makes the study of its structure in more detail challenging. 
The fibers formed under a large range of conditions, although they seemed to require 
an acidic phospholipid (e.g., phosphatidylglycerol, phosphatidylserine or cardiolipin). 
A threshold amount of negatively charged phospholipid was required to initiate fiber 
formation. When cyt c was incubated with liposomes composed of pure zwitterionic 
POPC, no fibers formed. Experiments with varying lipid compositions indicated that a 
threshold concentration of approximately XPS= 0.1 was required for fiber formation with 
cyt c. No differences could be detected between liposomes composed of POPG/POPC, 
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brain-PS/POPC and brain-PS/SOPC. These data resemble the known requirement for a 
critical surface charge density for electrostatic cyt c membrane binding, suggesting that 
A-site (or C- site) membrane binding is required to initiate fiber formation (Kinnunen et al, 
1994; Rytömaa & Kinnunen, 1994).
 To further characterize the fiber structure, we incorporated trace amounts of a fluo-
rescent phospholipid analogue NBD-PG into liposomes prior to fiber formation. Under 
the fluorescence microscope, these fibers had evenly distributed fluorescence, demon-
strating the presence of phospholipids throughout the fiber structure. Strictly speaking, 
this fluorescence pattern only indicates the presence of the fluorescent phospholipid ana-
logue but does not provide information regarding the localization of the protein in this 
structure (IV, Fig. 3). Given the known robust interaction between cyt c and phospholip-
ids and the fact that the conditions required for fiber formation were identical to those 
required for binding of cyt c to liposomes, we think it is highly probable that the fiber is 
an organized protein-phospholipid microstructure.
The appearance of the cyt c–phospholipid fibers resembled amyloids. To test this 
hypothesis, we used Congo red to stain the fibers and found that following visualization 
with cross-polarized light, the fibers almost uniformly emitted the green birefringence 
characteristic of amyloid structures (IV, Fig. 2). This suggests the presence of an amyloid-
like structure (Nilsson, 2004).
Many soluble proteins are known to bind acidic phospholipid membranes in a 
manner analagous to cyt c. Therefore, we wondered if the formation of fibers with an 
amyloid-like structure is a universal behavior for acidic phospholipid–binding proteins. 
To test this hypothesis, we examined the behavior of lysozyme, insulin, glyceraldehyde-
3-phosphate dehydrogenase, myoglobin, transthyretin, histone H1 and α-lactalbumin; 
all of these proteins resemble cyt c in that they are generally water-soluble proteins with 
clusters of cationic amino acids on their surface. All except transthyretin have been pre-
viously reported to bind anionic phospholipid membranes in vitro through a mechanism 
similar to cyt c (see Table I in the original publication IV for references).
Indeed, we found that all of the tested proteins were capable of inducing the for-
mation of protein-lipid aggregates upon incubation with liposomes made of brain-PS/
POPC. The resulting fibers were almost indistinguishable from one another, although 
the visible red color of the cyt c fibers was absent from fibers produced by other proteins. 
The variation in individual fibers of a single sample was larger than that for fibers formed 
from different proteins. As a consequence, we were unable to use our methodology to 
36 · esa k. j. tuominen: phospholipid–cytochrome c interactions
study such heterogeneous samples. Later, the structure of the cyt c–phospholipid fibers 
was studied with FITR- and AFM, and the presence of amyloid-like beta-sheet protein 
structures was confirmed (Alakoskela et al, 2006). These studies also demonstrated signifi-
cant variation in the protein structure of these phospholipid–cyt c aggregates. Segments 
of individual continuous fibers displayed both amyloid (beta-sheet) and native cyt c 
conformations. The blue color seen in some of the fibers was found to be linked to the 
amyloid-containing segments, probably as a result of the periodic structure of the fiber 
causing light interference (Alakoskela et al, 2006).
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Lack of liposome aggregation by Nle91 (I)
Previous studies have provided evidence for multiple phospholipid-binding sites in cyt 
c (Rytömaa & Kinnunen, 1994). The aggregation of liposomes by cyt c is consistent with this 
model. At low cyt c:negatively charged phospholipid ratios, the electrostatic repulsion of 
the liposomes seems to prevent aggregation. After surface charge neutralization, the wt 
cyt c molecule is able to bind two separate liposomes and cause aggregation; ultimately, 
this aggregation results in rupture and/or fusion of the liposomes and the formation of 
macroscopic aggregates. Because the aggregation behavior can be disrupted with the 
perturbation of a single amino acid, Arg91, this activity is likely to be mediated by a 
defined site. Importantly, the Arg91 residue is evolutionarily invariant, suggesting that 
this amino acid may constitute an evolutionarily conserved phospholipid-binding site. 
Other than phospholipid and ATP binding, no other hypothesis has been put forth to 
account for the conservation of this residue (Ow et al, 2008)(II). 
Eventually, this rapid liposome aggregation seems to favor the formation of amyloid-
containing fibers. However, they seem to be separate processes as turbidity-increasing 
aggregation is not required for fiber formation. Also, the kinetics of the liposome aggre-
gation detected using scattering is an order of a magnitude faster than the appearance 
of the fibers (I, IV and unpublished observation). Unfortunately, the availability of Nle91 
cyt c and technical difficulties prevented us from studying the kinetics of fiber formation 
in more detail. 
ATP binding affects the conformation of lipid-bound cyt c (II)
Over the years, evidence has accumulated in support of a direct role for ATP in the regu-
lation of the biological function of cyt c . The Nle91 mutant was designed to perturb the 
invariant Arg 91 and to assess its effect on ATP binding. The modification of arginine to 
norleucine removes a charge without altering protein stability or the secondary/tertiary 
structure. This modification is much more conservative and specific than previous modi-
fications of this binding site, in particular N7,N8-(1,2-dihydroxycyclohex-1,2-ene)diyl-
L-arginine 91-cyt c and 8-azido-ATP cyt c, which introduce bulky chemical moieties into 
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this binding site (Craig & Wallace, 1991b). The affinity filtration data demonstrate that ATP 
binding of this mutant is markedly lower but not completely lost (II). Accordingly, the 
ATP-mediated conformational changes were found to be diminished in magnitude but 
still detectable. The inability of this mutant to aggregate liposomes was dramatically dif-
ferent from the wt protein (I).
All of the methods that were used to study ATP binding to phospholipid-bound cyt 
c demonstrated a conformational change in C-site-bound cyt c. Using Soret region CD 
spectroscopy to monitor the heme environment, it became clear that the conformation 
of cyt c in the presence of ATP is distinct from any of the conformations seen for free or 
lipid-bound cyt c in the absence of ATP. Therefore, the presence of ATP favors a previ-
ously unknown conformational state of membrane-bound cyt c. Subsequent work has 
demonstrated that ATP affects the lipid-induced peroxidase activity of cyt c. Thus, ATP 
binding is likely to regulate mitochondrial respiration and apoptosis (Kagan et al, 2005; 
Sinibaldi et al, 2005).
Extended lipid anchorage (III)
A number of biological reactions are linked to membranes in vivo, and membrane bind-
ing provides an additional regulatory step for these reactions. When the diffusion of 
the reactants is restricted to a two-dimensional membrane surface, the reaction rates 
can increase 1000 fold. The blood coagulation cascade is a well-known example of an 
enzymatic cascade being controlled by peripheral membrane association (Kinnunen et al, 
1994; Nelsestuen, 1999). The physical state of the membrane can also directly affect the activ-
ity of the proteins bound to it (Kinnunen, 1996). Because peripheral membrane association 
is involved in numerous cellular reactions, it is important to understand the molecular 
mechanism underlying these interactions.
In addition to electrostatic interactions, hydrogen bonding and partial penetra-
tion, extended phospholipid anchorage has been proposed as a mechanism underlying 
peripheral membrane interactions. This mechanism involves hydrophobic interactions, 
but the peripherally bound proteins do not penetrate into the membrane. Extended 
phospholipid anchorage can facilitate membrane binding with a low dissociation con-
stant and allows for the lateral pressure profile of the membrane to regulate membrane 
binding (Kinnunen, 1996). The lateral pressure profile and HII propensity are two physical 
properties of membranes and membrane lipids that are defined by the molecular geom-
etry of the membrane components. Phospholipids with bulky hydrophobic acyl chains 
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and relatively small headgroups have an increased propensity to form non-lamellar lipid 
phases (e.g., hexagonal HII-phase) instead of bilayers to relieve the pressure profile in 
the membrane. This property would also promote extended phospholipid anchorage of 
membrane proteins, as extending side chains from the membrane relieves lateral pres-
sure. Therefore, the lipid composition could directly affect the ability of a protein to bind 
the membrane via an extended anchorage. It should be noted that cardiolipin, which is 
the physiological membrane ligand for C-site cyt c binding, has four acyl chains and a 
uniquely high HII-propensity. Additionally, the molecular structure of CL readily toler-
ates the extended conformation of one or possibly two acyl chains, which may be accom-
modated in the hydrophobic cavities of cyt c (Sinibaldi et al, 2010).
Many previously published results are consistent with extended phospholipid anchor-
age being the mechanism for the membrane association of cyt c, but the work reported in 
publication III provides the first direct evidence that an extended membrane phospho-
lipid acyl chain can bind inside a peripheral membrane protein. Other groups have since 
verified these results (Kagan et al, 2005; Kalanxhi & Wallace, 2007; Sinibaldi et al, 2010).
Figure 6
A schematic representation of a cyt c bound onto a lipid bilayer.
40 · esa k. j. tuominen: phospholipid–cytochrome c interactions
Fibrous protein-lipid aggregates (IV)
Amyloid formation is associated with a number of severe human diseases, includ-
ing Alzheimer’s disease, systemic amyloidosis, Parkinson’s disease and prion diseases. 
While some of these diseases are associated with genetic mutations that result in amino 
acid changes, most cases occur in individuals with a normal genotype and amino acid 
sequence. Therefore, the propensity to form amyloid fibrils is probably intrinsic to all 
proteins at some level. Different environments may favor amyloid formation even for 
proteins that naturally do not have a high propensity to form amyloids. Therefore, the 
differences in the amyloidogenicity of proteins are qualitative, not quantitative in nature. 
The physicochemical basis of amyloid formation remains poorly understood. In par-
ticular, the events leading to the formation of amyloids from normal proteins in vivo are 
still largely unknown. In general, the conditions that have been found to trigger amyloid 
formation in vitro, such as low pH, reduced dielectricity and hydrophobic solvents, are 
not relevant in vivo. Therefore, there are probably unknown additional factors contribut-
ing to amyloidogenesis in vivo. 
The aggregates that we observed forming in the presence of PS-containing liposomes 
appear similar to disease-related amyloids. The fact that acidic phospholipid–contain-
ing membranes can facilitate amyloid fibril formation at a neutral pH suggests that the 
interaction between cationic proteins and negatively charged membranes could also 
be involved in disease-related amyloid formation in vivo. Indeed, this mechanism has 
already been suggested for several proteins, including the Aβ peptide, α-synuclein and 
prions (Chi et al, 2008; Morillas et al, 1999; Terzi et al, 1994; Volles et al, 2001). Phospholipids bearing 
a net negative charge are abundant in various intracellular membranes and are readily 
available for surface aggregation by proteins. Importantly, the externalization of acidic 
phospholipids to the outer leaflet of the plasma membrane is increased during inflamma-
tion and apoptosis, possibly also favoring lipid-induced amyloidogenesis of extracellular 
proteins. Externalization of PS also increases in aging blood erythrocyte membranes. 
The presence of PS on the outer leaflet of erythrocyte plasma membranes has been dem-
onstrated to act as a signal for cell senescence that controls the removal of aged cells from 
circulation (Boas et al, 1998).
Because we observed that a variety of cationic proteins are capable of forming similar 
amyloid-containing structures with phospholipids, we suggest that this behavior could 
be a general phenomenon (IV).
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At high cyt c:acidic phospholipid ratios, we observed rapid aggregation of large unila-
mellar liposomes. This activity is abolished by the modification of the invariant Arg91, 
indicating that cyt c possesses multiple phospholipid-binding sites. 
ATP binds to both free and membrane-bound cyt c, causing conformational changes 
in the C-site membrane–bound protein. The ATP-mediated effects are reduced by the 
modification of Arg91. The evolutionally conserved Arg91 is part of a phospholipid- and 
ATP-binding site, which perhaps explains its conservation throughout evolution.
Liposomes composed of brominated phospholipids quench the intrinsic fluorescence 
of [Zn2+-heme] cyt c, indicating that an acyl chain of a membrane phospholipid interacts 
with the heme group inside the protein. This result provides direct evidence in support 
of the extended lipid anchorage of cyt c to phospholipid membranes. 
We observed the formation of fibrous lipid-protein aggregates under conditions 
favoring cyt c binding to acidic phospholipids. These fibers had an amyloid-type protein 
structure. A similar behavior was also observed for a number of other soluble phospho-
lipid-binding proteins. These results suggest that peripheral membrane binding may be a 
general mechanism by which amyloids form under physiological conditions.
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Mårten Wikström for their constructive comments and professor Dan Lindholm for 
agreeing to act as the custos in the defence.
I thank Juha-Matti Alakoskela for his friendship and numerous discussions about 
science and life in general. Juha-Matti has a superior understanding of science and I have 
learned a lot from him while working together. 
Mikko Parry I would like to thank for his friendship. Since the beginning of our 
studies we have experienced learning medicine, research and clinical work as peers, not 
forgetting many interesting past-time activities. I want to thank Mikko also for proof-
reading the manuscript of this dissertation.
ACKNOWLEDGEMENTS · 43
I would like to sincerely thank my parents Marjatta and Esko Tuominen for their 
everlasting support and encouragement.
I wish to thank my beloved wife Laura-Elina Lahtela. Your support made it finally 
possible for me to finish this work.
New York, December 2010
Esa K. J. Tuominen
44 · esa k. j. tuominen: phospholipid–cytochrome c interactions
REFERENCES
Aguzzi A, O’Connor T (2010) Protein aggregation diseases: pathogenicity and 
therapeutic perspectives. Nature Reviews Drug Discovery 9: 237-248
Alakoskela JM, Jutila A, Simonsen AC, Pirneskoski J, Pyhajoki S, Turunen R, Marttila 
S, Mouritsen OG, Goormaghtigh E, Kinnunen PKJ (2006) Characteristics of fibers 
formed by cytochrome c and induced by anionic phospholipids. Biochemistry 45: 
13447-13453
Anni H, Vanderkooi JM, Mayne L (1995) Structure of zinc-substituted cytochrome 
c: nuclear magnetic resonance and optical spectroscopic studies. Biochemistry 34: 
5744-5753
Basanez G, Sharpe J, Galanis J, Brandt T, Hardwick J, Zimmerberg J (2002) Bax-
type apoptotic proteins porate pure lipid bilayers through a mechanism sensitive to 
intrinsic monolayer curvature. J Biol Chem 277: 49360-49365
Belikova N, Vladimirov Y, Osipov A, Kapralov A, Tyurin V, Potapovich M, Basova 
L, Peterson J, Kurnikov I, Kagan V (2006) Peroxidase Activity and Structural 
Transitions of Cytochrome c Bound to Cardiolipin-Containing Membranes. 
Biochemistry 45: 4998-5009
Berger N, Sachse A, Bender J, Schubert R, Brandl M (2001) Filter extrusion of 
liposomes using different devices: comparison of liposome size, encapsulation 
efficiency, and process characteristics. Int J Pharm 223: 55-68
Bjursell G, Skoog L (1980) Control of nucleotide pools in mammalian cells. Antibiot 
Chemother 28: 78-85
Blauer G, Sreerama N, Woody RW (1993) Optical activity of hemoproteins in the Soret 
region. Circular dichroism of the heme undecapeptide of cytochrome c in aqueous 
solution. Biochemistry 32: 6674-6679
Boas FE, Forman L, Beutler E (1998) Phosphatidylserine exposure and red cell viability 
in red cell aging and in hemolytic anemia. Proc Natl Acad Sci U S A 95: 3077-3081
Bolen EJ, Holloway PW (1990) Quenching of tryptophan fluorescence by brominated 
phospholipid. Biochemistry 29: 9638-9643
Bushnell GW, Louie GV, Brayer GD (1990) High-resolution three-dimensional 
structure of horse heart cytochrome c. J Mol Biol 214: 585-595
Chi EY, Ege C, Winans A, Majewski J, Wu GH, Kjaer K, Lee KYC (2008) Lipid 
membrane templates the ordering and induces the fibrillogenesis of Alzheimer’s 
disease amyloid-beta peptide. Proteins 72: 1-24
Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. 
Annu Rev Biochem 75: 333-366
Chiti F, Dobson CM (2009) Amyloid formation by globular proteins under native 
conditions. Nature Chemical Biology 5: 15-22
REFERENCES · 45
Cortese JD, Voglino AL, Hackenbrock CR (1998) Multiple conformations of 
physiological membrane-bound cytochrome c. Biochemistry 37: 6402-6409
Corthesy BE, Wallace CJ (1986) The oxidation-state-dependent ATP-binding site of 
cytochrome c. A possible physiological significance. Biochem J 236: 359-364
Corthesy BE, Wallace CJ (1988) The oxidation-state-dependent ATP-binding site 
of cytochrome c. Implication of an essential arginine residue and the effect of 
occupancy on the oxidation-reduction potential. Biochem J 252: 349-355
Craig DB, Wallace CJ (1991a) The specificity and Kd at physiological ionic strength of 
an ATP-binding site on cytochrome c suit it to a regulatory role. Biochem J 279 ( Pt 
3): 781-786
Craig DB, Wallace CJ (1995) Studies of 8-azido-ATP adducts reveal two mechanisms 
by which ATP binding to cytochrome c could inhibit respiration. Biochemistry 34: 
2686-2693
Craig DB, Wallace CJA (1991b) The specificity and kd at physiological ionic-strength 
of an atp-binding site on cytochrome-c suit it to a regulatory role. Biochem J 279: 
781-786
Dawidowicz EA, Rothman JE (1976) Fusion and protein-mediated phospholipid 
exchange studied with single bilayer phosphatidylcholine vesicles of different density. 
Biochim Biophys Acta 455: 621-630
de Jongh HH, Killian JA, de Kruijff B (1992) A water-lipid interface induces a highly 
dynamic folded state in apocytochrome c and cytochrome c, which may represent a 
common folding intermediate. Biochemistry 31: 1636-1643
Ensign AA, Jo I, Yildirim I, Krauss TD, Bren KL (2008) Zinc porphyrin: A fluorescent 
acceptor in studies of Zn-cytochrome c unfolding by fluorescence resonance energy 
transfer. Proc Natl Acad Sci U S A 105: 10779-10784
Förster T (1948) Zwischenmolekulare energiewanderung und fluoreszenz. Annalen der 
Physik 437: 55-75
Gennis R (1989) Biomembranes: molecular structure and function: Springer New York.
Greenberg ME, Li XM, Gugiu BG, Gu XD, Qin J, Salomon RG, Hazen SL (2008) The 
lipid whisker model of the structure of oxidized cell membranes. J Biol Chem 283: 
2385-2396
Hagan RM, Worner-Gibbs J, Wilton DC (2008) The interaction of liver fatty-acid-
binding protein (FABP) with anionic phospholipid vesicles: is there extended 
phospholipid anchorage under these conditions? Biochem J 410: 123-129
Hao Z, Duncan G, Chang C, Elia A, Fang M, Wakeham A, Okada H (2005) Specific 
ablation of the apoptotic functions of cytochrome c reveals a differential requirement 
for cytochrome c and Apaf-1 in apoptosis. Cell 121: 579-591
Hauser H, Guyer W, Pascher I, Skrabal P, Sundell S (1980) Polar group conformation 
of phosphatidylcholine. Effect of solvent and aggregation. Biochemistry 19: 366-373
Hauser H, Pascher I, Sundell S (1988) Preferred conformation and dynamics of the 
glycerol backbone in phospholipids. An NMR and X-ray single-crystal analysis. 
Biochemistry 27: 9166-9174
46 · esa k. j. tuominen: phospholipid–cytochrome c interactions
Heikenwalder M, Federaii C, Von Boehmer L, Schwarz P, Wagner M, Zeller N, 
Flaybaeck J, Prinz M, Becher B, Aguzzi A (2007) Genninal center B cells are 
dispensable in prion transport and neuroinvasion. J Neuroimmunol 192: 113-123
Heimburg T, Hildebrandt P, Marsh D (1991) Cytochrome c-lipid interactions 
studied by resonance Raman and 31P NMR spectroscopy. Correlation between the 
conformational changes of the protein and the lipid bilayer. Biochemistry 30: 9084
Heimburg T, Marsh D (1995) Protein surface-distribution and protein-protein 
interactions in the binding of peripheral proteins to charged lipid membranes. 
Biophys J 68: 536-546
Holopainen J, Lehtonen J, Kinnunen P (1999) Evidence for the extended phospholipid 
conformation in membrane fusion and hemifusion. Biophys J 76: 2111-2120
Huang YY, Kimura T (1984) Thermodynamic parameters for the reduction reaction 
of membrane-bound cytochrome c in comparison with those of the membrane-free 
form: spectropotentiostatic determination with use of an optically transparent thin-
layer electrode. Biochemistry 23: 2231-2236
Jensen MO, Mouritsen OG (2004) Lipids do influence protein function - the 
hydrophobic matching hypothesis revisited. Biochim Biophys Acta 1666: 205-226
Kagan V, BayIr H, Belikova N, Kapralov O, Tyurina Y, Tyurin V, Jiang J, Stoyanovsky 
D, Wipf P, Kochanek P (2009) Cytochrome c/cardiolipin relations in mitochondria: 
a kiss of death. Free Radic Biol Med 46: 1439-1453
Kagan V, Tyurin V, Jiang J, Tyurina Y, Ritov V, Amoscato A, Osipov A, Belikova N, 
Kapralov A, Kini V (2005) Cytochrome c acts as a cardiolipin oxygenase required for 
release of proapoptotic factors. Nature Chemical Biology 1: 223-232
Kagan VE, Borisenko GG, Tyurina YY, Tyurin VA, Jiang J, Potapovich AI, Kini V, 
Amoscato AA, Fujii Y (2004) Oxidative lipidomics of apoptosis: redox catalytic 
interactions of cytochrome c with cardiolipin and phosphatidylserine. Free Radic 
Biol Med 37: 1963-1985
Kalanxhi E, Wallace C (2007) Cytochrome c impaled: investigation of the extended 
lipid anchorage of a soluble protein to mitochondrial membrane models. Biochem J 
407: 179
Khurana R, Uversky VN, Nielsen L, Fink AL (2001) Is Congo red an amyloid-specific 
dye? J Biol Chem 276: 22715-22721
Kim H, Du F, Fang M, Wang X (2005) Formation of apoptosome is initiated by 
cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on 
Apaf-1. Proc Natl Acad Sci U S A 102: 17545
Kinnunen PK, Koiv A, Lehtonen JY, Rytomaa M, Mustonen P (1994) Lipid dynamics 
and peripheral interactions of proteins with membrane surfaces. Chem Phys Lipids 
73: 181-207
Kinnunen PKJ (1996) On the molecular-level mechanisms of peripheral protein-
membrane interactions induced by lipids forming inverted non-lamellar phases. 
Chem Phys Lipids 81: 151-166
REFERENCES · 47
Kinnunen PKJ (1999) Peripheral interactions on lipid membrane surfaces. Chem Phys 
Lipids 101: 1-2
Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of 
cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. 
Science 275: 1132-1136
Li F, Srinivasan A, Wang Y, Armstrong R, Tomaselli K, Fritz L (1997a) Cell-specific 
induction of apoptosis by microinjection of cytochrome c. Bcl-xL has activity 
independent of cytochrome c release. J Biol Chem 272: 30299
Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X 
(1997b) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex 
initiates an apoptotic protease cascade. Cell 91: 479-489
Lin J, Wu S, Lau WT, Chan SI (1995) 8-Azido-ATP modification of cytochrome c: 
retardation of its electron-transfer activity to cytochrome c oxidase. Biochemistry 34: 
2678-2685
Liu X, Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program 
in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157
Luhrs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Doeli H, Schubert D, Riek 
R (2005) 3D structure of Alzheimer’s amyloid-beta(1-42) fibrils. Proc Natl Acad Sci 
U S A 102: 17342-17347
MacDonald RC, MacDonald RI, Menco BP, Takeshita K, Subbarao NK, Hu LR (1991) 
Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. 
Biochim Biophys Acta 1061: 297-303
Margoliash E, Frohwirt N (1959) Spectrum of horse-heart cytochrome c. Biochem J 71: 
570-572
Mattila J, Sabatini K, Kinnunen P (2008) Interaction of Cytochrome c with 
1-Palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine: Evidence for Acyl Chain 
Reversal. Langmuir 24: 4157-4160
McIntosh DB, Parrish JC, Wallace CJ (1996) Definition of a nucleotide binding site on 
cytochrome c by photoaffinity labeling. J Biol Chem 271: 18379-18386
Moore GR, Pettigrew GW (1990) Cytochromes c: Evolutionary, Structural and 
Physicochemical Aspects, Berlin: Springer-Verlag.
Morillas M, Swietnicki W, Gambetti P, Surewicz WK (1999) Membrane environment 
alters the conformational structure of the recombinant human prion protein. J Biol 
Chem 274: 36859-36865
Mouritsen O (2005) Life-as a matter of fat: Springer Berlin.
Muga A, Mantsch H, Surewicz W (1991a) Membrane binding induces destabilization 
of cytochrome c structure. Biochemistry 30: 7219-7224
Muga A, Mantsch HH, Surewicz WK (1991b) Membrane binding induces 
destabilization of cytochrome c structure. Biochemistry 30: 7219-7224
48 · esa k. j. tuominen: phospholipid–cytochrome c interactions
Mustonen P, Virtanen JA, Somerharju PJ, Kinnunen PK (1987) Binding of 
cytochrome c to liposomes as revealed by the quenching of fluorescence from 
pyrene-labeled phospholipids. Biochemistry 26: 2991-2997
Nantes IL, Zucchi MR, Nascimento OR, Faljoni-Alario A (2001) Effect of heme 
iron valence state on the conformation of cytochrome c and its association with 
membrane interfaces. A CD and EPR investigation. J Biol Chem 276: 153-158
Nelsestuen GL (1999) Significance of reduced dimensionality in reaction kinetics: 
impact of multi-site particles. Chem Phys Lipids 101: 37-44
Nelsestuen GL, Lim TK (1977) Equilibria involved in prothrombin- and blood-clotting 
factor X-membrane binding. Biochemistry 16: 4164-4171
Nicholls P (1974) Cytochrome c binding to enzymes and membranes. Biochim Biophys 
Acta 346: 261
Nilsson MR (2004) Techniques to study amyloid fibril formation in vitro. Methods 34: 
151-160
Oellerich S, Lecomte S, Paternostre M, Heimburg T, Hildebrandt P (2004) Peripheral 
and integral binding of cytochrome c to phospholipids vesicles. J Phys Chem B 108: 
3871-3878
Ow YP, Green DR, Hao Z, Mak TW (2008) Cytochrome c: functions beyond 
respiration. Nat Rev Mol Cell Biol 9: 532-542
Pinheiro TJ, Elove GA, Watts A, Roder H (1997) Structural and kinetic description of 
cytochrome c unfolding induced by the interaction with lipid vesicles. Biochemistry 
36: 13122-13132
Qian CM, Yao Y, Tong YF, Wang JF, Tang WX (2003) Structural analysis of zinc-
substituted cytochrome c. J Biol Inorg Chem 8: 394-400
Quinn PJ, Dawson RMC (1969a) Interaction of cytochrome c with monolayers of 
phosphatidylethanolamine. Biochem J 113: 791-803
Quinn PJ, Dawson RMC (1969b) Interactions of cytochrome c and 14c 
carboxymethylated cytochrome c with monolayers of phosphatidylcholine, 
phosphatidic acid and cardiolipin. Biochem J 115: 65-75
Rochet JC, Lansbury PT, Jr. (2000) Amyloid fibrillogenesis: themes and variations. 
Curr Opin Struct Biol 10: 60-68
Rytömaa M, Kinnunen PK (1994) Evidence for two distinct acidic phospholipid-
binding sites in cytochrome c. J Biol Chem 269: 1770-1774
Rytömaa M, Kinnunen PK (1995) Reversibility of the binding of cytochrome c to 
liposomes. Implications for lipid-protein interactions. J Biol Chem 270: 3197-3202
Rytömaa M, Mustonen P, Kinnunen PK (1992) Reversible, nonionic, and 
pH-dependent association of cytochrome c with cardiolipin-phosphatidylcholine 
liposomes. J Biol Chem 267: 22243-22248
REFERENCES · 49
Saiki M, Honda S, Kawasaki K, Zhou DS, Kaito A, Konakahara T, Morii H (2005) 
Higher-order molecular packing in amyloid-like fibrils constructed with linear 
arrangements of hydrophobic and hydrogen-bonding side-chains. J Mol Biol 348: 
983-998
Salamon Z, Tollin G (1996a) Surface plasmon resonance studies of complex 
formation between cytochrome c and bovine cytochrome c oxidase incorporated 
into a supported planar lipid bilayer. I. Binding of cytochrome c to cardiolipin/
phosphatidylcholine membranes in the absence of oxidase. Biophys J 71: 848-857
Salamon Z, Tollin G (1996b) Surface plasmon resonance studies of complex formation 
between cytochrome c and bovine cytochrome c oxidase incorporated into a 
supported planar lipid bilayer. II. Binding of cytochrome c to oxidase-containing 
cardiolipin/phosphatidylcholine membranes. Biophys J 71: 858-867
Salamon Z, Tollin G (1997) Interaction of horse heart cytochrome c with lipid bilayer 
membranes: effects on redox potentials. J Bioenerg Biomembr 29: 211-221
Santucci R, Ascoli F (1997) The Soret circular dichroism spectrum as a probe for the 
heme Fe(III)-Met(80) axial bond in horse cytochrome c. J Inorg Biochem 68: 211-
214
Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, 
Thompson MJ, Balbirnie M, Wiltzius JJW, McFarlane HT, Madsen AO, Riekel C, 
Eisenberg D (2007) Atomic structures of amyloid cross-beta spines reveal varied 
steric zippers. Nature 447: 453-457
Schmittschmitt JP, Scholtz JM (2003) The role of protein stability, solubility, and net 
charge in amyloid fibril formation. Protein Sci 12: 2374-2378
Sekijima Y, Wiseman RL, Matteson J, Hammarstrom P, Miller SR, Sawkar AR, Balch 
WE, Kelly JW (2005) The biological and chemical basis for tissue-selective amyloid 
disease. Cell 121: 73-85
Serpell LC, Sunde M, Benson MD, Tennent GA, Pepys MB, Fraser PE (2000) The 
protofilament substructure of amyloid fibrils. J Mol Biol 300: 1033-1039
Sinibaldi F, Howes B, Piro M, Polticelli F, Bombelli C, Ferri T, Coletta M, Smulevich 
G, Santucci R (2010) Extended cardiolipin anchorage to cytochrome c: a model for 
protein–mitochondrial membrane binding. J Biol Inorg Chem 15: 689-700
Sinibaldi F, Mei G, Polticelli F, Piro MC, Howes BD, Smulevich G, Santucci R, Ascoli 
F, Fiorucci L (2005) ATP specifically drives refolding of non-native conformations of 
cytochrome c. Protein Sci 14: 1049-1058
Speck SH, Neu CA, Swanson MS, Margoliash E (1983) Role of phospholipid in the low 
affinity reactions between cytochrome c and cytochrome oxidase. FEBS Lett 164: 
379-382
Spooner PJ, Watts A (1991) Reversible unfolding of cytochrome c upon interaction 
with cardiolipin bilayers. 2. Evidence from phosphorus-31 NMR measurements. 
Biochemistry 30: 3880-3885
50 · esa k. j. tuominen: phospholipid–cytochrome c interactions
Stewart JM, Blakely JA, Johnson MD (2000) The interaction of ferrocytochrome c with 
long-chain fatty acids and their CoA and carnitine esters. Biochem Cell Biol 78: 675-
681
Stryer L (1978) Fluorescence energy transfer as a spectroscopic ruler. Annu Rev 
Biochem 47: 819-846
Stuart R, Neupert W (1990) Apocytochrome c: an exceptional mitochondrial precursor 
protein using an exceptional import pathway. Biochimie 72: 115-121
Terzi E, Holzemann G, Seelig J (1994) Alzheimer beta-amyloid peptide-25-35 - 
electrostatic interactions with phospholipid-membranes. Biochemistry 33: 7434-
7441
Vanderkooi JM, Adar F, Erecinska M (1976) Metallocytochromes c: characterization of 
electronic absorption and emission spectra of Sn4+ and Zn2+ cytochromes c. Eur J 
Biochem 64: 381-387
Vanderkooi JM, Erecinska M (1975) Cytochrome c interaction with membranes. 
Absorption and emission spectra and binding characteristics of iron-free cytochrome 
c. Eur J Biochem 60: 199-207
Vik SB, Georgevich G, Capaldi RA (1981) Diphosphatidylglycerol is required for 
optimal activity of beef heart cytochrome c oxidase. Proc Natl Acad Sci U S A 78: 
1456-1460
Virchow R (1854) Ueber eine im Gehirn und Rückenmark des Menschen aufgefundene 
Substanz mit der chemischen Reaction der Cellulose. Virchows Arch 6: 135-138
Volles MJ, Lee SJ, Rochet JC, Shtilerman MD, Ding TT, Kessler JC, Lansbury PT 
(2001) Vesicle permeabilization by protofibrillar alpha-synuclein: Implications for 
the pathogenesis and treatment of Parkinson’s disease. Biochemistry 40: 7812-7819
Wallace CJ, Rose K (1983) The semisynthesis of analogues of cytochrome c. 
Modifications of arginine residues 38 and 91. Biochem J 215: 651-658
Wiedmer SK, Hautala J, Holopainen JM, Kinnunen PK, Riekkola ML (2001) Study on 
liposomes by capillary electrophoresis. Electrophoresis 22: 1305-1313
Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X 
(1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria 
blocked. Science 275: 1129-1132
Zhivotovsky B, Orrenius S, Brustugun O, Döskeland S (1998) Injected cytochrome c 
induces apoptosis. Nature 391: 449-450
Zucchi MR, Nascimento OR, Faljoni-Alario A, Prieto T, Nantes IL (2003) Modulation 
of cytochrome c spin states by lipid acyl chains: a continuous-wave electron 
paramagnetic resonance (CW-EPR) study of haem iron. Biochem J 370: 671-678
